The 10-item LURN Symptom Index (LURN SI-10) Detects Additional Symptoms and Shows Convergent Validity With the IPSS in Men Presenting With Lower Urinary Tract Symptoms

Published:November 09, 2022DOI:


      To determine how the LURN-SI-10, a novel questionnaire developed by the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN), compares with the International Prostate Symptom Score (IPSS) in men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). Specifically, to assess convergent validity and determine how frequently the LURN-SI-10 identifies symptoms not captured by the IPSS.

      Materials and Methods

      Men presenting with BPH/LUTS were prospectively administered LURN-SI-10 and IPSS questionnaires. Urinary incontinence (UI) including post-void dribbling (PVD), urgency urinary incontinence (UUI), stress urinary incontinence (SUI), as well as bladder pain were considered present if the patient reported “about half the time or more” on LURN-SI-10. Correlations between LURN-SI-10 and IPSS were assessed as continuous and categorical variables. Multivariable linear regression analysis was performed to determine associations with symptom scores.


      LURN-SI-10 and IPSS were highly correlated in men with BPH/LUTS (r = 0.82, n = 429), as were respective bother and quality of life scores (ρ = 0.74). The LURN-SI-10 identified additional symptoms including PVD (24%), UUI (13%), SUI (2%), and pain (8%). Men with any UUI, SUI, or PVD had on average a 7.6-point higher LURN-SI-10 score than those without UI (P<.001) and 8.0-point higher IPSS score than those without UI (P<.001).


      The LURN-SI-10 correlates strongly with the IPSS, but the LURN-SI-10 identifies additional important symptomatology in men with LUTS. This additional information may improve the evaluation and treatment of men with BPH/LUTS. Further prospective studies of the LURN-SI-10 is warranted.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lerner LB
        • McVary KT
        • Barry MJ
        • et al.
        Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-Initial work-up and medical management.
        J Urol. 2021; 206: 806-817
        • Barry MJ
        • Fowler FJ
        • O'Leary MP
        • et al.
        The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association.
        J Urol. 1992; 148: 1549-1557
        • Helfand BT
        • Smith AR
        • Lai HH
        • et al.
        Prevalence and characteristics of urinary incontinence in a treatment seeking male prospective cohort: results from the LURN study.
        J Urol. 2018; 200: 397-404
        • Weinfurt KP
        • Griffith JW
        • Flynn KE
        • et al.
        The comprehensive assessment of self-reported urinary symptoms: a new tool for research on subtypes of patients with lower urinary tract symptoms.
        J Urol. 2019; 201: 1177-1183
        • Cella D
        • Smith AR
        • Griffith JW
        • et al.
        A new outcome measure for LUTS: symptoms of lower urinary tract dysfunction research network symptom Index-29 (LURN SI-29) questionnaire.
        Neurourol Urodyn. 2019; 38: 1751-1759
        • Cella D
        • Smith AR
        • Griffith JW
        • et al.
        A new brief clinical assessment of lower urinary tract symptoms for women and men: LURN SI-10.
        J Urol. 2020; 203: 164-170
        • Glaser AP
        • Mansfield S
        • Smith AR
        • et al.
        Impact of sleep disturbance, physical function, depression and anxiety on male lower urinary tract symptoms: results from the symptoms of lower urinary tract dysfunction research network (LURN).
        J Urol. 2022; 208: 155-163
        • Lerner LB
        • McVary KT
        • Barry MJ
        • et al.
        Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-Surgical evaluation and treatment.
        J Urol. 2021; 206: 818-826
        • Maserejian NN
        • Kupelian V
        • McVary KT
        • Doshi M
        • Link CL
        • McKinlay JB.
        Prevalence of post-micturition symptoms in association with lower urinary tract symptoms and health-related quality of life in men and women.
        BJU Int. 2011; 108: 1452-1458
        • Markland AD
        • Goode PS
        • Redden DT
        • Borrud LG
        • Burgio KL.
        Prevalence of urinary incontinence in men: results from the national health and nutrition examination survey.
        J Urol. 2010; 184: 1022-1027
        • D'Ancona C
        • Haylen B
        • Oelke M
        • et al.
        The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction.
        Neurourol Urodyn. 2019; 38: 433-477
        • Anger JT
        • Saigal CS
        • Stothers L
        • et al.
        The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey.
        J Urol. 2006; 176: 2103-2108
        • Flynn KE
        • Mansfield SA
        • Smith AR
        • et al.
        Can 7 or 30-Day recall questions capture self-reported lower urinary tract symptoms accurately?.
        J Urol. 2019; 202: 770-778